CPAP therapy is prescribed for breathing. The mask, the air pressure, the nightly routine — all of it exists to keep the upper airway open during sleep and prevent the repeated oxygen drops and arousals that define obstructive sleep apnea. But a study published in Innovation in Aging suggests CPAP may be doing something else entirely: protecting the brain.
Researchers at the University of Florida, Johns Hopkins University, the University of Maryland, and UC San Diego tracked 777 older adults with obstructive sleep apnea over 10 years and found that those who used CPAP showed measurably slower cognitive decline than those who did not. The finding reframes CPAP not just as a respiratory device but as a potential tool for preserving cognitive function during aging.
How the Study Worked
The research team used data from the National Health and Aging Trends Study (NHATS), a nationally representative longitudinal study of Medicare beneficiaries, linked with Medicare claims data through the National Institute on Aging's LINKAGE Enclave. From the 2011 enrollment cohort, they identified 777 participants who had at least one inpatient or outpatient Medicare claim with an obstructive sleep apnea diagnosis and were free of cognitive impairment at baseline.
CPAP treatment was defined as at least one Medicare claim for CPAP at any point during the study period. Cognitive performance was assessed annually using a composite score derived from NHATS measures of executive function, orientation, and memory recall, tracked as a continuous outcome from 2011 through 2021.
This design has a notable strength: rather than measuring cognition at two time points and looking for a difference, the researchers modeled the trajectory of cognitive change over a full decade. That provides a much more granular picture of how cognition evolves with and without treatment.
The Key Finding
In adjusted models controlling for age, education, sex, race, and comorbidities, CPAP-treated participants showed an annual cognitive decline of 0.03 factor score units per year. Participants without CPAP treatment declined an additional 0.02 units per year — a faster trajectory that, compounded over a decade, represents a clinically meaningful difference in cognitive function.
The numbers may sound small in isolation, but cognitive decline is a cumulative process. A difference of 0.02 units per year sustained over 10 years amounts to a 0.2-unit gap in cognitive scores — enough to distinguish between normal aging and the early stages of cognitive impairment in many assessment frameworks.
Why Sleep Apnea Damages the Brain
The biological plausibility behind this finding is well established. Obstructive sleep apnea subjects the brain to two forms of repeated injury every night: intermittent hypoxia (cyclical drops in blood oxygen as breathing stops and restarts) and sleep fragmentation (dozens or hundreds of brief arousals that prevent consolidated deep sleep and REM sleep).
Both mechanisms are independently linked to neurodegeneration. Intermittent hypoxia triggers oxidative stress and inflammation in brain tissue, particularly in the hippocampus and prefrontal cortex — regions critical for memory and executive function. Sleep fragmentation impairs the brain's glymphatic system, which clears neurotoxic waste products including amyloid-beta and tau during deep sleep. When that clearance process is disrupted night after night for years, the proteins accumulate.
A separate meta-analysis of 23 studies found that the pooled prevalence of cognitive impairment among adult OSA patients was 36.92%. Untreated OSA has also been associated with the onset of mild cognitive impairment approximately 12 years earlier than in people without sleep-disordered breathing.
Limitations to Consider
The study is observational, not a randomized trial. People who use CPAP may differ systematically from those who do not — they may be more health-conscious, more engaged with medical care, or have milder comorbidities. The researchers adjusted for many of these factors, but residual confounding is possible.
The CPAP treatment definition was also broad: at least one Medicare claim for CPAP at any point during the 10-year study. This captures the fact that someone was prescribed and used CPAP but does not measure adherence. Some participants may have used CPAP consistently for a decade; others may have tried it and stopped.
A randomized controlled trial assigning older adults with OSA to CPAP versus no treatment would provide stronger evidence, but such a trial raises ethical questions given that CPAP is already standard of care for symptomatic sleep apnea.
What This Means for Patients
If you have obstructive sleep apnea and struggle with CPAP adherence, this study provides a reason beyond daytime sleepiness to persist with treatment. The cognitive benefits of CPAP may not be immediately perceptible — you will not feel your hippocampus thanking you — but over years, the cumulative difference in brain health may be substantial.
For older adults with sleep apnea who have not been evaluated for cognitive changes, this research supports the case for cognitive screening as part of routine sleep medicine follow-up. And for clinicians, the findings reinforce that CPAP is not just managing a breathing problem. It may be protecting a brain.
